respiratorysystem
Roughly 5,800 hospitalisations from bronchiolitis were avoided in France thanks to the new preventive medicine nirsevimab, Public Health France said on Friday. The health agency cited two studies that showed that the antibody, which is marketed under the name Beyfortus, was effective at preventing severe cases of the illness in newborns caused by respiratory syncytial virus (RSV). The common respiratory virus causes cold-like symptoms but can be dangerous for newborns and older adults. It is the leading cause of paediatric hospitalisation in Europe. Cases of the virus surged following the COVI...
Euronews (English)
Health officials are investigating whether there's a link between two new RSV vaccines and cases of a rare nervous system disorder in older US adults. The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said on Thursday. And the available information is too limited to establish whether the shots caused the illnesses, they added. But the numbers are higher than expected and officials are gathering more information to determine if the vaccines are causing the problem. The data was presented at a meeting of an expert panel that ...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら